- Correction
- Open Access
- Published:
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
The Journal of Headache and Pain volume 23, Article number: 161 (2022)
Correction: J Headache Pain 23, 142 (2022)
https://doi.org/10.1186/s10194-022-01515-8
Following publication of the original article [1], the author group has identified an error in Fig. 1. The correct figure is given below.
The original article [1] has been corrected.
Reference
Gantenbein AR, Agosti R, Kamm CP et al (2022) Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. J Headache Pain 23:142. https://doi.org/10.1186/s10194-022-01515-8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Gantenbein, A.R., Agosti, R., Kamm, C.P. et al. Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. J Headache Pain 23, 161 (2022). https://doi.org/10.1186/s10194-022-01530-9
Published:
DOI: https://doi.org/10.1186/s10194-022-01530-9